Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.

PHASE3CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone/metformin

Trial Locations (93)

3550

GSK Investigational Site, Sant Joan d'Alacant

10789

GSK Investigational Site, Berlin

11009

GSK Investigational Site, Cadiz

12347

GSK Investigational Site, Berlin

12351

GSK Investigational Site, Berlin

13057

GSK Investigational Site, Berlin

14467

GSK Investigational Site, Potsdam

14612

GSK Investigational Site, Falkensee

16132

GSK Investigational Site, Genoa

16303

GSK Investigational Site, Schwedt

17019

GSK Investigational Site, La Rochelle

18012

GSK Investigational Site, Granada

20246

GSK Investigational Site, Hamburg

22041

GSK Investigational Site, Hamburg

22607

GSK Investigational Site, Hamburg

28006

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28100

GSK Investigational Site, Alcobendas/Madrid

28935

GSK Investigational Site, Móstoles/Madrid

31100

GSK Investigational Site, Treviso

31139

GSK Investigational Site, Hildesheim

32549

GSK Investigational Site, Bad Oeynhausen

33170

GSK Investigational Site, Pordenone

34246

GSK Investigational Site, Vellmar

35128

GSK Investigational Site, Padua

35203

GSK Investigational Site, Rennes

35403

GSK Investigational Site, St-Malo

36002

GSK Investigational Site, Pontevedra

36200

GSK Investigational Site, Vigo/Pontevedra

36381

GSK Investigational Site, Schlüchtern

38820

GSK Investigational Site, Halberstadt

41466

GSK Investigational Site, Neuss

41751

GSK Investigational Site, Viersen

42600

GSK Investigational Site, Montbrison

43100

GSK Investigational Site, Parma

44093

GSK Investigational Site, Nantes

44137

GSK Investigational Site, Dortmund

46010

GSK Investigational Site, Valencia

47574

GSK Investigational Site, Goch

48960

GSK Investigational Site, Galdakano

49000

GSK Investigational Site, Angers

49300

GSK Investigational Site, Cholet

51065

GSK Investigational Site, Cologne

51069

GSK Investigational Site, Cologne

51092

GSK Investigational Site, Reims

52070

GSK Investigational Site, Aachen

54201

GSK Investigational Site, Toul

55469

GSK Investigational Site, Simmern

55545

GSK Investigational Site, Bad Kreuznach

55624

GSK Investigational Site, Rhaunen

56322

GSK Investigational Site, Lorient

57610

GSK Investigational Site, Altenkirchen

59100

GSK Investigational Site, Roubaix

59269

GSK Investigational Site, Beckum

59507

GSK Investigational Site, Douai

60326

GSK Investigational Site, Frankfurt am Main

66740

GSK Investigational Site, Saarlouis

67061

GSK Investigational Site, Ludwigshafen am Rhein

67346

GSK Investigational Site, Speyer

68161

GSK Investigational Site, Mannheim

68199

GSK Investigational Site, Mannheim

68549

GSK Investigational Site, Ilvesheim

69200

GSK Investigational Site, Vénissieux

69394

GSK Investigational Site, Lyon

69495

GSK Investigational Site, Pierre-Bénite

74889

GSK Investigational Site, Sinsheim

75015

GSK Investigational Site, Paris

77971

GSK Investigational Site, Kippenheim

78333

GSK Investigational Site, Stockach

80469

GSK Investigational Site, Munich

81373

GSK Investigational Site, Munich

81549

GSK Investigational Site, Munich

89568

GSK Investigational Site, Hermaringen

91106

GSK Investigational Site, Corbeil-Essonnes

91360

GSK Investigational Site, Épinay-sur-Orge

93143

GSK Investigational Site, Bondy

94550

GSK Investigational Site, Künzing

94574

GSK Investigational Site, Wallerfing

99867

GSK Investigational Site, Gotha

A-1030

GSK Investigational Site, Vienna

A-1060

GSK Investigational Site, Vienna

01219

GSK Investigational Site, Dresden

01307

GSK Investigational Site, Dresden

01705

GSK Investigational Site, Freital

01796

GSK Investigational Site, Pirna

06112

GSK Investigational Site, Halle

06114

GSK Investigational Site, Halle

07907

GSK Investigational Site, Schleiz

06126

GSK Investigational Site, Perugia

Unknown

GSK Investigational Site, Alicante

08022

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

08208

GSK Investigational Site, Sabadell (Barcelona)

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00069836 - Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. | Biotech Hunter | Biotech Hunter